Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Non-Current Assets (2016 - 2026)

Bio-Techne has reported Non-Current Assets over the past 17 years, most recently at $1.9 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 7.39% year-over-year to $1.9 billion; the TTM value through Dec 2025 reached $7.9 billion, down 6.2%, while the annual FY2025 figure was $245.7 million, 2.16% down from the prior year.
  • Non-Current Assets for Q4 2025 was $1.9 billion at Bio-Techne, down from $1.9 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $2.2 billion in Q3 2023 and troughed at $207.9 million in Q2 2021.
  • A 5-year average of $1.5 billion and a median of $1.8 billion in 2022 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: rose 20.3% in 2023 and later decreased 8.18% in 2025.
  • Year by year, Non-Current Assets stood at $1.7 billion in 2021, then rose by 4.88% to $1.8 billion in 2022, then increased by 19.01% to $2.1 billion in 2023, then decreased by 4.87% to $2.0 billion in 2024, then fell by 7.39% to $1.9 billion in 2025.
  • Business Quant data shows Non-Current Assets for TECH at $1.9 billion in Q4 2025, $1.9 billion in Q3 2025, and $245.7 million in Q2 2025.